New "nightmare bacteria" cannot withstand UV

As drug-resistant pathogens continue to spread throughout the U.S., hundreds of hospitals throughout the country are deploying Tru-D SmartUVC UVC disinfection robots to help stop the spread of dangerous superbugs or "nightmare bacteria," as the CDC calls them. Chemical-free and environmentally-friendly, UVC disinfection has been validated by a CDC-funded randomized clinical trial to reduce the risk of acquisition and infection of four major superbugs, including C. diff, by a cumulative 30 percent.

"Since its inception in 2007, Tru-D has been committed to providing the safest hospital environments possible and reducing the risk of acquiring harmful infections such as C. diff, MRSA and VRE," said Chuck Dunn, CEO and President of Tru-D SmartUVC. "Our patented technology has been validated by leading researchers in infection control and epidemiology and adopted by prestigious health systems throughout the U.S."

Tru-D allows hospital staff to easily and confidently disinfect virtually any environment, including patient rooms, intensive care units, operating rooms, emergency rooms and public areas. The UVC disinfection robot kills deadly pathogens and common health care-associated infection culprits such as C. diff, Methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacteriaceae (CRE) and other bacteria that compromise patient outcomes.

Register as Visitor to CPhI China 2018!